Composition:

Each 10 ml Contains:
L-Ornithine L-Aspartate 5 gm.
Water for Injection IP q.s.

Indications:

-Chronic manifestation of Hepatic Encephalopathy in cirrhotic patients.
-Bouts of Overt Hepatic Encephalopathy.
-Hepatitis with hyperammonemia both in the cases of incipient disturbance of consciousness (Pre-coma) and clouding of consciousness (Coma).
-Liver Cirrhosis

Profile:

LOLA contains a combination of two amino acids. It works by protecting the liver from harmful chemical substances.

Dosage Form:

Infusion Concentrate for Dilution in I.V. Slow Drip only
L-Ornithine L-Aspartate 5gm/10ml injection